{
    "nctId": "NCT02415725",
    "briefTitle": "Early Detection of Lymphedema After Cancer Treatments",
    "officialTitle": "Early Detection of Secondary Lymphedema After Cancer Treatments",
    "overallStatus": "UNKNOWN",
    "conditions": "Lymphadenectomy, Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "PREVENTION",
    "enrollmentCount": 120,
    "primaryOutcomeMeasure": "number of lymphatic vessels visualized",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Patients who will undergo lymphadenectomy (either large lymphadenectomy or sentinel lymph node biopsy) for oncologic reason (gynaecologic, urologic or mammary cancer, melanoma and other skin cancer) without measurable or observable limb lymphedema.\n* Informed consent form signed.\n\nExclusion Criteria:\n\n* Allergy to iodine.\n* Incapaciy to give informed consent.\n* \\< 18 years.\n* Pregnancy or breastfeeding.\n* Coronary disease.\n* Advanced renal impairment.\n* Hyperthyroidism.",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}